A promoter genotype and oxidative stress potentially link resistin to human insulin resistance.
about
An inflammatory cascade leading to hyperresistinemia in humansData-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes.Efficacy of antioxidant treatment in reducing resistin serum levels: a randomized studyAssociation of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring StudyA at single nucleotide polymorphism-358 is required for G at -420 to confer the highest plasma resistin in the general Japanese populationAdipose tissue collagen VI in obesity.Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissueThe G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects.Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection.Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Lifestyle advice follow-up improve glycemic control, redox and inflammatory status in patients with type 2 diabetesThe physiological role of resistin and its connection with metabolic diseases.Adipokines and the Right Ventricle: The MESA-RV Study.Over expression of resistin in adipose tissue of the obese induces insulin resistance.Reactive oxygen species, reactive nitrogen species and antioxidants in etiopathogenesis of diabetes mellitus type-2Bioinformatic analysis of functional proteins involved in obesity associated with diabetes.Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.Obesity and polymorphisms in genes regulating human adipose tissue.Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity.Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic responseMacrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins.Association of plasma levels of resistin with subcutaneous fat mass and markers of inflammation but not with metabolic determinants or insulin resistanceCorrelation of resistin with inflammatory and cardiometabolic markers in obese adolescents with and without metabolic syndrome.Genetic Determination of Serum Levels of Diabetes-Associated AdipokinesInflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.The Central Role of Biometals Maintains Oxidative Balance in the Context of Metabolic and Neurodegenerative Disorders.Is rs34861192 or rs1862513 a more promising variant for determining plasma resistin in an aged Japanese population?Resistin polymorphisms are associated with muscle, bone, and fat phenotypes in white men and women.Differences in Mitochondrial Coupling Reveal a Novel Signature of Mitohormesis in Muscle of Healthy Individuals.Improvement of glucose intolerance by combination of pravastatin and olmesartan in type II diabetic KK-A(y) mice.Relationships between human serum resistin, inflammatory markers and insulin resistance.Effect of resistin on vascular endothelium secretion dysfunction in rats.Circulating retinol-binding protein 4 and metabolic syndrome in the elderly.Association of resistin polymorphisms with resistin levels and lipid profile in children.Genome-wide scan of resistin mRNA expression in omental adipose tissue of baboons.Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study
P2860
Q24796813-D7E37035-B981-4AEF-B1E9-C923A939B806Q24811670-68308295-68BE-4D05-B306-BB28BE59BCB6Q28469198-A88287FC-6020-49B1-BAF4-9899BE4F7528Q28755370-954966CA-BF59-487A-A8BC-E2E7DF9758D7Q33543084-68462939-8EB5-4A35-A8B6-9182FA0A83DFQ33644457-66DF8762-452D-440A-98DB-504B7CDF4756Q33707592-A59AA162-259B-469C-A1C2-A95AC78187EAQ33910196-A97A3867-C2CF-4065-9F9B-3BE631F6E6ABQ34031701-A61110AF-68C4-4C6C-82D9-AFD89B3E05EBQ34074789-DA4CB627-31AE-4BCF-B81C-FE15374A467FQ34553461-DBBA1DE5-C74E-4021-B010-E08570E3D8C6Q34779049-4E1A1A04-73DF-4964-ADA8-633725FCC8ECQ34787532-C6CD8DA7-3B3C-4604-8F24-A744D3A5F5EEQ35727731-2B8322F8-1E6F-4887-BAA5-927187595709Q35766863-0B46FE1D-F51F-44EF-BE73-67B6204F3880Q36103354-C5AB6E96-73AE-4C4E-8DBF-0768D5255C4AQ36263001-8C9C5899-7F48-4745-8E5A-C97B6D1C5102Q36735365-56E7E83D-9F0D-4AC5-B25A-07ED7492BC90Q36814772-93CD889D-9CB2-4E92-BDB1-0EE69E540DC5Q36847564-69C54574-AA0B-4433-A448-A02EC2D6F55BQ36849442-65AC21D7-AD35-41EE-B8E4-33B8888B0CD8Q37105363-FA7CBAF5-13AB-4F22-AB78-AB15687E0883Q37111330-90B3DF8F-BF08-46E1-A9A7-CFC099D74813Q37112231-D4152BE0-0931-4D63-99BF-293901FD4351Q37284789-6A259535-BE45-49ED-9B18-DC9AFCCB2094Q38313193-BBCB1882-D38E-48A3-96C2-BE9433167EDFQ38727331-2927C6C9-237B-437F-9267-BB1FFBACD4AFQ39255497-7544405F-C005-4ECB-B935-D027FD1CD33DQ41023080-4D3C3502-82F4-4CE4-B115-C8C0F44D9797Q43801998-A0D22E1A-24A3-462A-9948-75DAE2B73C26Q44927087-506EDB1E-3E02-4C2D-A54C-C8562D3775F5Q45095477-1BC702C3-2433-4B38-A0B2-382FF1808949Q45991482-6277CCAC-C412-4CEC-ADB9-BECC4F686977Q46619133-05841EA0-8539-48F1-9CE5-1AC58C2849CBQ46961508-FDC9AE07-9AA9-4591-BCB0-5CC3AE471109Q51375913-10E57090-7929-484B-899B-C06E7B0FACE3Q53480204-801990AD-AFFE-4E4D-A4C2-B7A5576FB803Q53887632-207EADB1-6415-4F7B-9FB1-017C7DA8F9A8Q57848758-C549621A-9036-43E0-A9D0-59518592ABC0
P2860
A promoter genotype and oxidative stress potentially link resistin to human insulin resistance.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A promoter genotype and oxidat ...... n to human insulin resistance.
@ast
A promoter genotype and oxidat ...... n to human insulin resistance.
@en
A promoter genotype and oxidat ...... n to human insulin resistance.
@nl
type
label
A promoter genotype and oxidat ...... n to human insulin resistance.
@ast
A promoter genotype and oxidat ...... n to human insulin resistance.
@en
A promoter genotype and oxidat ...... n to human insulin resistance.
@nl
prefLabel
A promoter genotype and oxidat ...... n to human insulin resistance.
@ast
A promoter genotype and oxidat ...... n to human insulin resistance.
@en
A promoter genotype and oxidat ...... n to human insulin resistance.
@nl
P2093
P1433
P1476
A promoter genotype and oxidat ...... n to human insulin resistance.
@en
P2093
Chantal Charbonneau
George Argyropoulos
Lenka Janderová
Steve R Smith
P304
P356
10.2337/DIABETES.52.7.1611
P407
P577
2003-07-01T00:00:00Z